 |
|
CODE
|
PROBE
|
ACC.N
|
MAP
|
UCSC May 2004
|
REMARKS
|
B-L |
|
|
|
|
|
HLA translocation |
 |
17P
|
RP11-666A8 |
AC015802 |
17q25.1 |
chr17:71,921,323-72,127,076 |
|
B-A |
|
|
|
|
|
HyA inversion |
 |
17Q
|
RP11-1033I8 |
BES |
17q25.3 |
chr17:77,586,262-77,802,604 |
|
B-N |
NLE
|
CH271-127K22 |
BES |
|
chr17:77,802,324/chr2:99,469,092 |
HLA16p&16p |
 |
17O
|
RP11-647F2 |
AC103809 |
17q25.1 |
chr17:69,679,276-69,878,103 |
HLA16p&crosshyb |
B-A |
|
|
|
|
|
HyA inversion |
 |
|
RP11-300G13 |
BES |
17q24.3 |
chr17:65,539,247-65,725,860 |
|
 |
|
RP11-481P7 |
BES |
17q24.2 |
chr17:62,182,470-62,330,115 |
|
 |
17N
|
RP11-346K10 |
BES |
17q24.1 |
chr17:61,533,516-61,702,132 |
HLA16p &8q HLA16p&16q |
B-A |
NLE
|
CH271-156E13 |
BES |
|
chr17:61,651,062-chr2:73,661,408 |
HLA translocation HLA16p |
CH271-219C13 |
BES |
|
chr17:61,672,774-chr2:73,672,665 |
 |
2I
|
RP11-582H21 |
AC074008 |
2p13.2 |
chr2:73,469,289-73,628,727 |
HLA16p&16q |
 |
|
RP11-495B16 |
AC109638 |
2p12 |
chr2:82,669,826-82,774,612 |
|
 |
2J
|
RP11-554H10 |
AC012671 |
2p11.2 |
chr2:88,432,100-88,630,793 |
|
B-H |
|
|
|
|
|
|
 |
2M
|
RP11-67L14 |
AC079753 |
2q13 |
chr2:113,258,399-113,412,612 |
|
 |
|
RP11-907H10 |
BES |
2q13 |
chr2:112,919,644-113,117,886 |
|
 |
|
RP11-519H15 |
AC005040 |
2q12.3 |
chr2:106,939,422-107,129,370 |
|
B-N |
NLE
|
CH271-127K22 |
BES |
|
chr2:99,469,092-chr17:77,802,324 |
HLA16p&16p |
 |
2L
|
RP11-111H13 |
BES |
2q11.2 |
chr2:99,271,614-99,450,504 |
|
 |
2K
|
RP11-468G5 |
AC009238 |
2q11.1 |
chr2:95,325,519-95,527,879 |
|
|
|
CENTROMERE
|
|
|
|
|
 |
17E
|
RP11-195H9 |
BES |
17p11.2 |
chr17:18,246,554-18,445,952 |
|
 |
|
RP11-958E14 |
BES |
17p11.2 |
chr17:17,586,396-17,798,015 |
|
 |
17C
|
RP11-92B11 |
|
17q25.1 |
chr17:16,467,786-16,646,713 |
HLA16q &8q |
B-A |
|
|
|
|
|
HyA inversion |
 |
2I
|
RP11-582H21 |
AC074008 |
2p13.1 |
chr2:73,469,289-73,628,727 |
HLA16q&16p |
 |
|
RP11-1115A12 |
BES |
2p14 |
chr2:64,940,189-65,080,881 |
|
 |
2H
|
RP11-511I11 |
AC009501 |
2p15 |
chr2:63,142,442-63,299,614 |
|
 |
|
RP11-1114A19 |
BES |
2p16.2 |
chr2:54,612,178-54,738,558 |
|
 |
2G
|
RP11-133M22 |
BES |
2p21 |
chr2:47,437,263-47,599,117 |
|
 |
2F
|
RP11-339H12 |
AC010883 |
2p21 |
chr2:43,250,442-43,465,973 |
|
 |
2E
|
RP11-366P6 |
BES |
2p22.3 |
chr2:33,921,612-34,093,881 |
|
B-L |
|
|
|
|
|
HLA translocation |
 |
19J
|
RP11-22H18 |
|
19q13.31 |
chr19:49,372,243-49,525,206 |
HLA16q&10p |
 |
|
RP11-77I7 |
|
19q13.32 |
chr19:50,999,952-51,169,950 |
|
 |
19K
|
RP11-194H9 |
BES |
19q13.32 |
chr19:51,551,265-51,719,089 |
|
B-A |
|
|
|
|
|
HyA inversion |
 |
19B
|
RP11-137E22 |
BES |
19p13.3 |
chr19:5,663,924-5,851,279 |
|
 |
19A
|
RP11-75H6 |
BES |
19p13.3 |
chr19:902,641-1,095,485 |
|
|